Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Shamash

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Prostate Cancer and Prostatic Diseases|July 26, 2020
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxisLara Pemberton, Kenrick Ng, Ursula McGovern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trialsDean A Fennell, Amit Parmar, Jonathan Shamash, et al.
Urologia Internationalis|October 27, 2010
The effect of sunitinib on immune subsets in metastatic clear cell renal cancerThomas Powles, Simon Chowdhury, Mark Bower, et al.
Cancer|June 22, 2010
A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancerJonathan Shamash, Justin Stebbing, Chris Sweeney, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
A brief report on the safety study of induction chemotherapy followed by synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH studySimon Hughes, Janet Liong, Aisha Miah, et al.
European Urology Focus|May 9, 2020
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and SurgeryConstantine Alifrangis, Olivia Lucas, Sarah Benafif, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaJustin Stebbing, Thomas Powles, Kirsty McPherson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2012
The hazards of cross comparing the drug toxicity results from different trials in metastatic renal cancer: in response to a letter from Dr. Catalá-LópezThomas Powles, Naveed Sarwar, Rob Jones, et al.
BJU International|November 29, 2014
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approachWaleed Badreldin, Jonathan Krell, Simon Chowdhury, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2012
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancerThomas Powles, Naveed Sarwar, Rob Jones, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Prostate Cancer and Prostatic Diseases|July 26, 2020
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxisLara Pemberton, Kenrick Ng, Ursula McGovern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trialsDean A Fennell, Amit Parmar, Jonathan Shamash, et al.
Urologia Internationalis|October 27, 2010
The effect of sunitinib on immune subsets in metastatic clear cell renal cancerThomas Powles, Simon Chowdhury, Mark Bower, et al.
Cancer|June 22, 2010
A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancerJonathan Shamash, Justin Stebbing, Chris Sweeney, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
A brief report on the safety study of induction chemotherapy followed by synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH studySimon Hughes, Janet Liong, Aisha Miah, et al.
European Urology Focus|May 9, 2020
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and SurgeryConstantine Alifrangis, Olivia Lucas, Sarah Benafif, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaJustin Stebbing, Thomas Powles, Kirsty McPherson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2012
The hazards of cross comparing the drug toxicity results from different trials in metastatic renal cancer: in response to a letter from Dr. Catalá-LópezThomas Powles, Naveed Sarwar, Rob Jones, et al.
BJU International|November 29, 2014
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approachWaleed Badreldin, Jonathan Krell, Simon Chowdhury, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2012
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancerThomas Powles, Naveed Sarwar, Rob Jones, et al.
Pageof 11